LANXESS Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de LANXESS de 108.2% y 2.8% por año respectivamente. Se prevé que el BPA crezca en un 116.7% al año. Se espera que la rentabilidad financiera sea de 3.2% en 3 años.

Información clave

108.2%

Tasa de crecimiento de los beneficios

116.7%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Chemicals	35.1%
Tasa de crecimiento de los ingresos	2.8%
Rentabilidad financiera futura	3.2%
Cobertura de analistas	Good
Última actualización	19 Nov 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Does LANXESS (ETR:LXS) Have A Healthy Balance Sheet?

Oct 30

Why We're Not Concerned About LANXESS Aktiengesellschaft's (ETR:LXS) Share Price

Sep 07

Is LANXESS (ETR:LXS) Using Debt Sensibly?

Jul 23

Is It Too Late To Consider Buying LANXESS Aktiengesellschaft (ETR:LXS)?

May 27

Why Investors Shouldn't Be Surprised By LANXESS Aktiengesellschaft's (ETR:LXS) P/S

May 08

Is There An Opportunity With LANXESS Aktiengesellschaft's (ETR:LXS) 42% Undervaluation?

Apr 20

LANXESS Aktiengesellschaft's (ETR:LXS) Intrinsic Value Is Potentially 28% Above Its Share Price

Apr 26

Is Now The Time To Look At Buying LANXESS Aktiengesellschaft (ETR:LXS)?

Feb 17

These 4 Measures Indicate That LANXESS (ETR:LXS) Is Using Debt Extensively

Jan 30

Is There An Opportunity With LANXESS Aktiengesellschaft's (ETR:LXS) 25% Undervaluation?

Jan 12

Is There Now An Opportunity In LANXESS Aktiengesellschaft (ETR:LXS)?

Nov 03

We Think LANXESS (ETR:LXS) Is Taking Some Risk With Its Debt

Oct 11

Is It Too Late To Consider Buying LANXESS Aktiengesellschaft (ETR:LXS)?

Aug 03

LANXESS (ETR:LXS) Has A Somewhat Strained Balance Sheet

Jul 11

LANXESS' (ETR:LXS) Dividend Will Be Increased To €1.05

May 09

LANXESS (ETR:LXS) Will Pay A Larger Dividend Than Last Year At €1.05

Apr 21

LANXESS' (ETR:LXS) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 04

LANXESS (ETR:LXS) Is Increasing Its Dividend To €1.05

Mar 13

At €53.00, Is It Time To Put LANXESS Aktiengesellschaft (ETR:LXS) On Your Watch List?

Feb 07

We Think LANXESS (ETR:LXS) Can Stay On Top Of Its Debt

Jan 17

At €59.04, Is It Time To Put LANXESS Aktiengesellschaft (ETR:LXS) On Your Watch List?

Oct 26

Previsiones de crecimiento de beneficios e ingresos

XTRA:LXS - Estimaciones futuras de los analistas y datos financieros pasados (EUR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	6,869	84	273	641	14
12/31/2025	6,626	-6	223	602	15
12/31/2024	6,414	-151	-2	426	15
9/30/2024	6,319	-690	71	377	N/A
6/30/2024	6,322	-822	407	708	N/A
3/31/2024	6,422	-951	323	629	N/A
12/31/2023	6,714	-843	512	838	N/A
9/30/2023	7,251	-280	433	785	N/A
6/30/2023	7,835	-65	32	414	N/A
3/31/2023	8,056	128	94	501	N/A
12/31/2022	8,088	184	-248	159	N/A
9/30/2022	7,794	191	-136	296	N/A
6/30/2022	7,190	147	-60	372	N/A
3/31/2022	6,660	146	-228	194	N/A
12/31/2021	6,101	116	-17	407	N/A
9/30/2021	5,925	119	-62	371	N/A
6/30/2021	5,805	105	7	444	N/A
3/31/2021	5,772	863	72	515	N/A
12/31/2020	6,104	892	129	585	N/A
9/30/2020	6,237	883	113	590	N/A
6/30/2020	6,480	938	185	677	N/A
3/31/2020	6,768	231	200	713	N/A
12/31/2019	6,802	255	135	643	N/A
9/30/2019	6,559	266	165	685	N/A
6/30/2019	6,641	243	148	665	N/A
3/31/2019	6,746	212	104	595	N/A
12/31/2018	6,824	190	104	586	N/A
9/30/2018	7,066	144	152	603	N/A
6/30/2018	6,990	138	N/A	737	N/A
3/31/2018	6,873	63	N/A	881	N/A
12/31/2017	6,530	23	N/A	868	N/A
9/30/2017	6,810	73	N/A	692	N/A
6/30/2017	7,021	83	N/A	627	N/A
3/31/2017	7,252	166	N/A	651	N/A
12/31/2016	7,699	192	N/A	689	N/A
9/30/2016	7,590	205	N/A	882	N/A
6/30/2016	7,622	184	N/A	768	N/A
3/31/2016	7,784	196	N/A	707	N/A
12/31/2015	7,902	165	N/A	692	N/A
9/30/2015	8,000	82	N/A	751	N/A
6/30/2015	8,087	76	N/A	762	N/A
3/31/2015	8,001	44	N/A	821	N/A
12/31/2014	8,006	47	N/A	797	N/A
9/30/2014	8,116	-89	N/A	718	N/A
6/30/2014	8,126	-113	N/A	895	N/A
3/31/2014	8,248	-159	N/A	810	N/A
12/31/2013	8,300	-159	N/A	641	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que LXS sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (1%).

Beneficios vs. Mercado: Se prevé que LXS sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.

Beneficios de alto crecimiento: Se espera que LXS sea rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (2.8% al año) de LXS crezcan más despacio que el mercado de German (5.6% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 2.8% al año) de LXS crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de LXS sea baja dentro de 3 años (3.2%).

LANXESS Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Consensus EPS estimates upgraded to €2.09 loss

Consensus EPS estimates fall by 11%

Consensus EPS estimates fall by 11%

Consensus EPS estimates fall by 11%

Consensus EPS estimates fall by 10%

Consensus EPS estimates upgraded to €1.61 loss, revenue downgraded

Recent updates

Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Does LANXESS (ETR:LXS) Have A Healthy Balance Sheet?

Consensus EPS estimates upgraded to €2.09 loss

UBE Corporation (TSE:4208) signed a contract to acquire Urethane Systems Business of LANXESS Aktiengesellschaft (XTRA:LXS) for an enterprise value of €460 million.

Why We're Not Concerned About LANXESS Aktiengesellschaft's (ETR:LXS) Share Price

Second quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Is LANXESS (ETR:LXS) Using Debt Sensibly?

Consensus EPS estimates fall by 11%

LANXESS Aktiengesellschaft Announces Executive Changes

Consensus EPS estimates fall by 11%

Is It Too Late To Consider Buying LANXESS Aktiengesellschaft (ETR:LXS)?

Upcoming dividend of €0.10 per share

Consensus EPS estimates fall by 11%

First quarter 2024 earnings released: €1.13 loss per share (vs €0.12 profit in 1Q 2023)

Why Investors Shouldn't Be Surprised By LANXESS Aktiengesellschaft's (ETR:LXS) P/S

Is There An Opportunity With LANXESS Aktiengesellschaft's (ETR:LXS) 42% Undervaluation?

Dividend reduced to €0.10

Consensus EPS estimates fall by 10%

Is LANXESS (ETR:LXS) Weighed On By Its Debt Load?

Consensus EPS estimates upgraded to €1.61 loss, revenue downgraded

What You Can Learn From LANXESS Aktiengesellschaft's (ETR:LXS) P/S

Lanxess Reportedly Seeks to Sell Polyurethane Ops

Price target decreased by 8.6% to €29.08

Is LANXESS (ETR:LXS) Using Too Much Debt?

New major risk - Revenue and earnings growth

New major risk - Revenue and earnings growth

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

LANXESS Aktiengesellschaft Proposes Dividend for the Fiscal Year 2023

A Look At The Fair Value Of LANXESS Aktiengesellschaft (ETR:LXS)

LANXESS Aktiengesellschaft to Report Q2, 2024 Results on Aug 09, 2024

Price target decreased by 9.1% to €33.45

Price target decreased by 7.2% to €34.82

LANXESS Aktiengesellschaft(XTRA:LXS) dropped from FTSE All-World Index (USD)

New major risk - Revenue and earnings growth

When Should You Buy LANXESS Aktiengesellschaft (ETR:LXS)?

These 4 Measures Indicate That LANXESS (ETR:LXS) Is Using Debt In A Risky Way

New major risk - Dividend sustainability

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Calculating The Fair Value Of LANXESS Aktiengesellschaft (ETR:LXS)

Consensus EPS estimates fall by 48%

Consensus EPS estimates fall by 88%

Price target decreased by 12% to €43.70

Investor sentiment deteriorates as stock falls 20%

When Should You Buy LANXESS Aktiengesellschaft (ETR:LXS)?

Upcoming dividend of €1.05 per share at 3.0% yield

Is LANXESS (ETR:LXS) A Risky Investment?

First quarter 2023 earnings released: EPS: €0.12 (vs €0.76 in 1Q 2022)

LANXESS Aktiengesellschaft's (ETR:LXS) Intrinsic Value Is Potentially 28% Above Its Share Price

Now 21% undervalued after recent price drop

Full year 2022 earnings: EPS misses analyst expectations

Consensus EPS estimates fall by 11%

Investor sentiment deteriorates as stock falls 19%

Is Now The Time To Look At Buying LANXESS Aktiengesellschaft (ETR:LXS)?

Now 20% undervalued

These 4 Measures Indicate That LANXESS (ETR:LXS) Is Using Debt Extensively

Now 22% undervalued

Is There An Opportunity With LANXESS Aktiengesellschaft's (ETR:LXS) 25% Undervaluation?

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: €0.97 (vs €0.46 in 3Q 2021)

Is There Now An Opportunity In LANXESS Aktiengesellschaft (ETR:LXS)?

We Think LANXESS (ETR:LXS) Is Taking Some Risk With Its Debt

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Is It Too Late To Consider Buying LANXESS Aktiengesellschaft (ETR:LXS)?

LANXESS (ETR:LXS) Has A Somewhat Strained Balance Sheet

LANXESS Aktiengesellschaft (XTRA:LXS) completed the acquisition of Microbial Control business unit of International Flavors & Fragrances Inc. (NYSE:IFF).

Investor sentiment deteriorated over the past week

LANXESS Aktiengesellschaft to Report Q3, 2023 Results on Nov 08, 2023

Advent International Corporation and LANXESS Aktiengesellschaft (XTRA:LXS) agreed to acquire Engineering Materials business of Royal DSM from Koninklijke DSM N.V. (ENXTAM:DSM) for €3.9 billion.

Investor sentiment improved over the past week